Imiquimod induces skin inflammation in humanized BRGSF mice with limited human immune cell activity
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281005 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Pernille Kristine Fisker Christensen und 6 weiteren Autor:innen. Beteiligte Einrichtung: LEO Pharma A/S, Ballerup, Denmark. Hauptthemen laut MEDLINE: Dermatitis, Psoriasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovationsfonden, LEO Pharma.
Abstract (Originalsprache)
Human immune system (HIS) mouse models can be valuable when cross-reactivity of drug candidates to mouse systems is missing. However, no HIS mouse models of psoriasis have been established. In this study, it was investigated if imiquimod (IMQ) induced psoriasis-like skin inflammation was driven by human immune cells in human FMS-related tyrosine kinase 3 ligand (hFlt3L) boosted (BRGSF-HIS mice). BRGSF-HIS mice were boosted with hFlt3L prior to two or three topical applications of IMQ. Despite clinical skin inflammation, increased epidermal thickness and influx of human immune cells, a human derived response was not pronounced in IMQ treated mice. However, the number of murine neutrophils and murine cytokines and chemokines were increased in the skin and systemically after IMQ application. In conclusion, IMQ did induce skin inflammation in hFlt3L boosted BRGSF-HIS mice, although, a limited human immune response suggest that the main driving cellular mechanisms were of murine origin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- LEO Pharma A/S, Ballerup, Denmark.
- Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
- Bioneer A/S, Hørsholm, Denmark.
ORCID-Profile: Pernille Kristine Fisker Christensen
Förderung
- Innovationsfonden
- LEO Pharma
Zitieren
APA
Christensen, P. K. F., Hansen, A. K., Skov, S., Martel, B. C., Larsen, J., Høyer-Hansen, M. H., & Koch, J. (2023). Imiquimod induces skin inflammation in humanized BRGSF mice with limited human immune cell activity. PLOS ONE. https://doi.org/10.1371/journal.pone.0281005
Vancouver
Christensen PKF, Hansen AK, Skov S, Martel BC, Larsen J, Høyer-Hansen MH, et al. Imiquimod induces skin inflammation in humanized BRGSF mice with limited human immune cell activity. PLOS ONE. 2023. doi:10.1371/journal.pone.0281005
BibTeX
@article{Christensen2023,
author = {Christensen, Pernille Kristine Fisker and Hansen, Axel Kornerup and Skov, Søren and Martel, Britta Cathrina and Larsen, Jesper and Høyer-Hansen, Maria Helena and Koch, Janne},
title = {Imiquimod induces skin inflammation in humanized BRGSF mice with limited human immune cell activity},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281005}
}
EUVIMED